Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical and pharmacologic experience with dibromodulcitol (NSC-104800). A new antitumor agent.

× No keyword cloud information.

5 in total

1. Dominance of resistance to the alkylating agent 1,2:5,6-dianhydrogalactitol in P388 mouse lymphoma hybrid cells.

Authors: I Pályi; J Bence; K Szikla; L Hullán
Journal: Cancer Chemother Pharmacol Date: 1989 Impact factor: 3.333

2. Randomized trial of radiation therapy (RT) plus dibromodulcitol (DBD) versus RT plus BCNU in high grade astrocytoma.

Authors: T E Elliott; R P Dinapoli; J R O'Fallon; J E Krook; J D Earle; R F Morton; R Levitt; L K Tschetter; B W Scheithauer; D M Pfeifle; D I Twito; R A Nelimark
Journal: J Neurooncol Date: 1997-07 Impact factor: 4.130

3. The binding of in vivo administered dibromodulcitol to the DNA, histone and non-histone of Yoshida ascites tumor cells.

Authors: E Institóris; L Holczinger; D Bánfi
Journal: Z Krebsforsch Klin Onkol Cancer Res Clin Oncol Date: 1974

4. [Correlation of the differences of biological effects and distribution parameters of 1,6-dibromohexitols].

Authors: L Institóris; E Dzurillay; J H Sebestyén; A Jeney; G Pethes
Journal: Z Krebsforsch Date: 1971

5. Comparative studies on the in vivo distribution pattern of dibromodulcitol and diepoxydulcitol.

Authors: G Pethes
Journal: Z Krebsforsch Klin Onkol Cancer Res Clin Oncol Date: 1973

5 in total